Related references
Note: Only part of the references are listed.Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications
Richard M. Bergenstal et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Prevention of gestational diabetes mellitus: a review of studies on weight management
Anne-Sophie Morisset et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Insulin analogues and cancer risk: cause for concern or cause celebre?
M. Pollak et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?
Hertzel C. Gerstein
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Dietary Glycemic Index, Glycemic Load, and Risk of Cancer: A Prospective Cohort Study
Stephanie Materese George et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Henry Buchwald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Massimiliano Cazzaniga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
Rob C. M. van Kruijsdijk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Expression and function of the insulin receptor substrate proteins in cancer
Katerina Mardilovich et al.
CELL COMMUNICATION AND SIGNALING (2009)
Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2009)
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2009)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
Do Cancer Cells Care If Their Host Is Hungry?
Michael Pollak
CELL METABOLISM (2009)
Peroxisome Proliferator-Activated Receptor gamma Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
Frank Ondrey
CLINICAL CANCER RESEARCH (2009)
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse et al.
CURRENT CANCER DRUG TARGETS (2009)
Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia
Peter C. Butler
DIABETES (2009)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Alcohol as a Risk Factor for Type 2 Diabetes A systematic review and meta-analysis
Dolly O. Baliunas et al.
DIABETES CARE (2009)
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
Doron Weinstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings
C. J. Currie
DIABETOLOGIA (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines
Ashish Shukla et al.
ENDOCRINE-RELATED CANCER (2009)
Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer
Brian M. Wolpin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bariatric surgery, weight reduction, and cancer prevention
Andrew G. Renehan
LANCET ONCOLOGY (2009)
A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish
Beatrice Secretan et al.
LANCET ONCOLOGY (2009)
Tumours with PI3K activation are resistant to dietary restriction
Nada Y. Kalaany et al.
NATURE (2009)
Insulin Receptor Expression by Human Prostate Cancers
Michael E. Cox et al.
PROSTATE (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Dietary Patterns and Prevention of Type 2 Diabetes: From Research to Clinical Practice; A Systematic Review
Christina-Maria Kastorini et al.
CURRENT DIABETES REVIEWS (2009)
Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative
Geoffrey C. Kabat et al.
CANCER CAUSES & CONTROL (2008)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2008)
Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I
E. Liefvendahl et al.
HORMONE AND METABOLIC RESEARCH (2008)
Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?
S. Jabbour
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
The impact of diabetes on survival following breast cancer
Lorraine L. Lipscombe et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Active smoking and the risk of type 2 diabetes - A systematic review and meta-analysis
Carole Willi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Glycemie index, glycemie load, and cereal fiber intake and risk of type 2 diabetes in US black women
Supriya Krishnan et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Anna Marie Mulligan et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
Rulla M. Tamimi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress
David R. Clemmons et al.
GROWTH HORMONE & IGF RESEARCH (2007)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
Cancer risks in thiazolidinedione users compared to other anti-diabetic agents
Carol Koro et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors
Adam Denley et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Rangaswamy Govindarajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Obesity and cancer risk: the role of the insulin-IGF axis
Andrew G. Renehan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study
Angela D. Liese et al.
PEDIATRICS (2006)
Effect of weight loss with lifestyle intervention on risk of diabetes
Richard F. Hamman et al.
DIABETES CARE (2006)
Physical activity and survival after colorectal cancer diagnosis
Jeffrey A. Meyerhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adult weight change and risk of postmenopausal breast cancer
AH Eliassen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC)
Tobias Pischon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Alan D. Lopez et al.
LANCET (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the risk of cancer with healthy food choices and physical activity
Lawrence H. Kushi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Smoking and incidence of diabetes among US adults: Findings from the Insulin Resistance Atherosclerosis Study
CG Foy et al.
DIABETES CARE (2005)
Racial differences in premenopausal endogenous hormones
SP Pinheiro et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
PPARγ as a therapeutic target for tumor angiogenesis and metastasis
D Panigrahy et al.
CANCER BIOLOGY & THERAPY (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Physical activity and survival after breast cancer diagnosis
MD Holmes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effect of alcohol consumption on diabetes mellitus - A systematic review
AA Howard et al.
ANNALS OF INTERNAL MEDICINE (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
HJ Burstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Physical activity and cancer prevention - Data from epidemiologic studies
IM Lee
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells
CE Clay et al.
JOURNAL OF LIPID RESEARCH (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Magnitude of peroxisome proliferator-activated receptor-γ activation is associated with important and seemingly opposite biological responses in breast cancer cells
CE Clay et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2001)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells
K Ohta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
P Kurtzhals et al.
DIABETES (2000)
Share Paper
